Keyword: GlaxoSmithKline

GlaxoSmithKline plans to close its skincare products plants in Sligo, Ireland, and lay off its 165 workers over the next three years.

A cabotegravir/rilpivirine combo as a monthly HIV treatment showed similar efficacy to a standard three-drug therapy.

Seqirus expects to offer 50 million flu vaccine doses, while GSK plans to boost its supplies to 40 million to 45 million, its highest total ever.

GlaxoSmithKline CEO Emma Walmsley has tapped a successor for longtime CFO Simon Dingemans—and he’ll have his work cut out for him.

Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.

Sanofi Pasteur is urging parents to make sure teens get a second meningococcal booster vaccine in a new ad campaign timed for back-to-school.

Shire could fill Takeda's gap of late-stage assets; GSK lays off 1,000 as a Bangladesh plant nears closure; Laekna gets two Novartis cancer drugs.

GSK, Merck, Sanofi, Pfizer and Seqirus topped the world's biggest vaccine companies list by 2017 revenue.

Merck's HPV shot, Gardasil, continued to gain steam in the second quarter, and execs see "significant" growth prospects ahead.

GlaxoSmithKline will close a manufacturing plant and lay off 1,000 employees in Bangladesh by year end.